Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial-Reference-Cited by-同舟云学术

Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial

Published:2023-11 Issue:3 Volume:117 Page:613-623
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Morris Brett A.^ORCID,Holmes Emma E.,Anger Nicholas J.,Cooley Gregory,Schuster Jessica M.,Hurst Newton,Baschnagel Andrew M.,Bassetti Michael F.,Blitzer Grace C.,Chappell Richard J.,Bayliss Robert A.,Morris Zachary S.,Ritter Mark A.,Floberg John M.

Funder

National Institutes of Health

University of Wisconsin Carbone Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference41 articles.

1. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics;Cronin;Cancer,2018

2. NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines;Schaeffer;J Natl Compr Canc Ne,2021

3. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

4. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation;Zaorsky;Radiother Oncol,2015

5. Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial;Kerkmeijer;J Clin Oncol,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer;European Urology Oncology;2023-11

3. Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases;Practical Radiation Oncology;2023-09